Press release
Hemostasis and Tissue Sealing Agents Market to Reach USD 8.3 Billion by 2034
Pune, India, November 7, 2025 - The Global Hemostasis and Tissue Sealing Agents Market is projected to grow from USD 4.5 billion in 2024 to approximately USD 8.3 billion by 2034, registering a CAGR of 6.3% during the forecast period (2025-2034), according to Exactitude Consultancy. The rising number of surgical procedures, growing geriatric population, and advancements in biologically derived sealants and adhesives are driving strong market expansion across hospitals and ambulatory surgical centers.Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/49145
Key Takeaways
• Market Size (2024): USD 4.5 Billion
• Forecast (2034): USD 8.3 Billion
• CAGR (2025-2034): 6.3%
• Key Segments: Product Type, Application, End User, and Region
• Leading Companies: Baxter International Inc., Johnson & Johnson (Ethicon), Becton, Dickinson and Company (BD), Pfizer Inc., CryoLife Inc., B. Braun Melsungen AG, Integra LifeSciences, and Mallinckrodt Pharmaceuticals
Market Story
Hemostasis and tissue sealing agents are crucial in modern surgery, ensuring effective bleeding control and minimizing postoperative complications. They are widely used in cardiovascular, orthopedic, neurological, and general surgical procedures to reduce recovery times and improve patient outcomes.
Recent years have witnessed strong growth in the adoption of biological sealants, such as fibrin-based and collagen-based formulations, due to their superior biocompatibility and natural healing support. At the same time, synthetic sealants and glues are gaining traction for their durability and precision in minimally invasive surgeries.
The trend toward robotic and laparoscopic procedures is accelerating the need for flexible, quick-acting hemostats and sealants that function effectively in confined surgical fields. Additionally, hospitals are increasingly adopting combination products that integrate mechanical, chemical, and biological modes of action to optimize performance.
Market Segmentation
By Product Type:
Topical Hemostats, Adhesive and Tissue Sealants, Fibrin Sealants, Collagen-Based Agents, Gelatin-Based Agents, Thrombin-Based Agents, Synthetic Glues
By Application:
Cardiovascular Surgery, General Surgery, Orthopedic Surgery, Neurosurgery, Gynecological Surgery, Others
By End User:
Hospitals, Ambulatory Surgical Centers, Specialty Clinics
By Region:
North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Explore Full Report here: https://exactitudeconsultancy.com/reports/49145/hemostasis-tissue-sealing-agents-market
Recent Developments
• Baxter International launched Floseal® Hemostatic Matrix with improved applicator design for minimally invasive surgeries.
• Ethicon (Johnson & Johnson) expanded its Evicel® Fibrin Sealant line to address tissue sealing in complex vascular procedures.
• CryoLife Inc. introduced BioGlue® Surgical Adhesive for use in cardiac and pulmonary surgeries.
• B. Braun Melsungen AG developed a new range of absorbable gelatin sponges to enhance hemostasis efficiency.
• Integra LifeSciences collaborated with research institutes to develop next-generation collagen scaffolds for regenerative wound care.
Expert Insight
"The future of surgical care is defined by precision, speed, and biocompatibility. Hemostasis and tissue sealing agents are evolving to deliver these outcomes - ensuring faster recovery, reduced blood loss, and superior healing efficiency,"
- Lead Medical Devices Analyst, Exactitude Consultancy.
Get Your Exclusive Offer with up to 10% Discount : https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=49145
Market Drivers
• Rising Surgical Procedures: Increasing global demand for complex and elective surgeries.
• Advances in Biomaterials: Development of natural and synthetic sealants with higher tensile strength and faster clotting.
• Minimally Invasive Techniques: Growth in laparoscopic and robotic surgeries requiring efficient sealant solutions.
• Expanding Healthcare Access: Rising infrastructure and healthcare investments in emerging economies.
Forecast & Regional Insights
North America leads the global market, accounting for over 42% of total revenue in 2024, supported by high surgical volumes, strong regulatory frameworks, and technological innovation in wound closure materials. Europe follows with robust healthcare systems emphasizing patient safety and surgical precision. The Asia-Pacific region is expected to record the fastest CAGR of 7.2%, driven by healthcare modernization, increased trauma cases, and growing hospital adoption of advanced hemostatic products across India, China, and Japan.
Conclusion
The hemostasis and tissue sealing agents market is poised for strong growth as surgical care moves toward efficiency and innovation. The convergence of biotechnology, materials science, and clinical precision is redefining wound management, making these agents indispensable for modern operating rooms worldwide.
This report is also available in the following languages : Japanese (止血組織シーリング剤市場), Korean (지혈 조직 밀봉제 시장), Chinese (止血组织密封剂市场), French (Marché des agents hémostatiques de scellement tissulaire), German (Markt für Hämostase-Gewebeversiegelungsmittel), and Italian (Mercato degli agenti sigillanti per l'emostasi dei tessuti), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/reports/49145/hemostasis-tissue-sealing-agents-market#request-a-sample
Related Reports
Hemostasis Market
https://exactitudeconsultancy.com/reports/71535/hemostasis-market
Automatic Coagulation System Market
https://exactitudeconsultancy.com/reports/54038/global-automatic-coagulation-system-market
Medical Polyvinyl Alcohol Sponge Market
https://exactitudeconsultancy.com/reports/58750/global-medical-polyvinyl-alcohol-sponge-market
Thromboelastograph Hemostasis Analyzers Market
https://exactitudeconsultancy.com/reports/59590/global-thromboelastograph-hemostasis-analyzers-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Hemostasis and Tissue Sealing Agents Market to Reach USD 8.3 Billion by 2034 here
News-ID: 4261610 • Views: …
More Releases from Exactitude Consultancy
Partial Seizure Market to Reach USD 11.24 Billion by 2034 Driven by Rising Epile …
Pune, India - December 2025 - The global Partial Seizure Market, valued at USD 6.82 billion in 2024, is projected to reach USD 11.24 billion by 2034, growing at a 5.2% CAGR (2025-2034), according to Exactitude Consultancy. Increasing global epilepsy burden, development of new anti-seizure medications (ASMs), and expanded access to neurological diagnostics are fueling strong market growth.
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/72069
Market Summary
The Partial Seizure Market…
Partial Epilepsy Market to Reach USD 9.36 Billion by 2034
Pune, India - December 2025 - The global Partial Epilepsy Market, valued at USD 5.84 billion in 2024, is projected to reach USD 9.36 billion by 2034, growing at a 4.8% CAGR (2025-2034), according to Exactitude Consultancy. Rising prevalence of focal (partial) seizures, development of improved anti-epileptic drugs (AEDs), and advancements in neuroimaging and neuromodulation therapies are key growth drivers.
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/72067
Market Summary
The Partial…
Nucleic Acid and Gene Therapies in Neuromuscular Disorders Market to Reach USD 1 …
Pune, India - December 2025 - The global Nucleic Acid and Gene Therapies in Neuromuscular Disorders Market, valued at USD 6.84 billion in 2024, is projected to reach USD 19.42 billion by 2034, growing at a robust 11.0% CAGR (2025-2034), according to Exactitude Consultancy. Rapid advancements in AAV-based gene therapies, antisense oligonucleotides (ASOs), RNA-targeting technologies, and improved diagnostic pathways are driving strong market momentum.
Download Full PDF Sample Copy of Market…
Prediabetes Market to Reach USD 29.84 Billion by 2034 Driven by Rising Global Di …
Pune, India - December 2025 - The global Prediabetes Market, valued at USD 14.62 billion in 2024, is projected to reach USD 29.84 billion by 2034, growing at a 7.2% CAGR (2025-2034), according to Exactitude Consultancy. The rising prevalence of insulin resistance, sedentary lifestyles, obesity, and increased screening initiatives are fueling substantial market growth.
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/72063
Market Summary
The Prediabetes Market is expanding rapidly as healthcare…
More Releases for Hemostasis
Hemostasis Diagnostics Market Forecast Overview, 2024-2033
The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.
Hemostasis Diagnostic Devices And Equipment Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.
The Market Size Is Expected To Reach $9.85 billion…
Hemostasis Valves Market Size, Share | Trend 2030
Exclusive Report by Ameco Research: Hemostasis Valves Market Size Projected to Reach USD 255 Billion by 2030, Growing at 5.80% CAGR
Ameco Research is proud to announce the launch of its latest market research report, Hemostasis Valves Market. This comprehensive report provides in-depth analysis and insights into the current market trends and future projections in the Industry/Market Segment. Ameco Research has been at the forefront of providing quality market research…
Hemostasis Diagnostics Market: Global Industry Analysis 2024
Hemostasis, the body’s normal physiological response to stop bleeding after a vascular injury, is a key procedure in the first line of action attempted post an injury, by the body itself or by medical respondents. Preventing significant loss of blood is vital for the survival of a patient, making hemostasis the focus of widespread research and study. Owing to the critical nature of the procedure, the hemostasis products market has…
Hemostasis Diagnostics Market: Global Markets & Advanced Technologies
Hemostasis, the body’s normal physiological response to stop bleeding after a vascular injury, is a key procedure in the first line of action attempted post an injury, by the body itself or by medical respondents. Preventing significant loss of blood is vital for the survival of a patient, making hemostasis the focus of widespread research and study. Owing to the critical nature of the procedure, the hemostasis products market has…
Hemostasis Products Market: Applications and Global Markets
This report on the global hemostasis products market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments.
The research is a combination of primary and secondary research. Primary research formed the bulk of our research efforts along with information collected from telephonic interviews and interactions via e-mails. Secondary research involved study…
Predictions for 2024: Hemostasis Products Market
The top four vendors operating in the global hemostasis products market, including Ethicon, Pfizer Inc., Baxter International, Inc., and CR Bard, Inc., accounted for a share of nearly 41% in the market in 2015, states Transparency Market Research in a recent report. In the seemingly fragmented market, where small- and medium-scale vendors accounted for over 59% in the overall market in the 2015, a large number of these players provided…
